Talk of dividends being under threat at companies such as Bristol-Myers Squibb , Pfizer and Lilly , combined with the increased need across industry to scale back on costs and the ever-present – and growing – pressure to keep pipelines strong and ...
Fears that a market correction was imminent pushed the equity markets down as January tapered out, with the Standard & Poors 500 moving below its 100-day moving average for the first time since April 2009.
For healthcare stocks, potentially the ...
In the equity markets, the investor wariness that was apparent during November continued into December, as investors sought alternative investment vehicles.
Mutual funds were being favoured in the US, while in Japan, fixed-income corporate bonds ...
After the rallying, the volatility, and the return of risk aversion.
November began with a mixed picture: upbeat US Institute of Supply Management (ISM) data, showing a third successive month of increasing factory activity, were taken by analysts to ...
